Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Pharmacological Research|December 1, 2021
iTReX: Interactive exploration of mono- and combination therapy dose response profiling dataDina ElHarouni, Yannick Berker, Heike Peterziel, et al.
Pharmaceuticals (Basel, Switzerland)|October 30, 2020
Rapid In Vivo Validation of HDAC Inhibitor-Based Treatments in Neuroblastoma Zebrafish XenograftsJagoda K Wrobel, Sara Najafi, Simay Ayhan, et al.
Cell Death & Disease|August 25, 2017
Three-dimensional tumor cell growth stimulates autophagic flux and recapitulates chemotherapy resistanceCorinna Bingel, Emily Koeneke, Johannes Ridinger, et al.
Scientific Reports|July 4, 2018
Dual role of HDAC10 in lysosomal exocytosis and DNA repair promotes neuroblastoma chemoresistanceJohannes Ridinger, Emily Koeneke, Fiona R Kolbinger, et al.
International Journal of Cancer|September 26, 2025
New cell lines expanding the diversity of Ewing sarcoma modelsMaximilian Kerkhoff, Christiane Schaefer, Wilhelm G Dirks, et al.
Clinical Pharmacology and Therapeutics|July 13, 2023
Key Pharmacokinetic Parameters of 74 Pediatric Anticancer Drugs Providing Assistance in Preclinical StudiesNora Jamaladdin, Romain Sigaud, Daniela Kocher, et al.
Neuro-Oncology Advances|April 27, 2022
Predictive modeling of resistance to SMO inhibition in a patient-derived orthotopic xenograft model of SHH medulloblastomaSonja Krausert, Sebastian Brabetz, Norman L Mack, et al.
Cancers|September 10, 2021
Combining APR-246 and HDAC-Inhibitors: A Novel Targeted Treatment Option for NeuroblastomaMichael Müller, Lisa Rösch, Sara Najafi, et al.
Cell Death and Differentiation|March 9, 2018
A kinome-wide RNAi screen identifies ALK as a target to sensitize neuroblastoma cells for HDAC8-inhibitor treatmentJing Shen, Sara Najafi, Sina Stäble, et al.
Pageof 5